WW International, Inc. (WW) News
Follow WW International, Inc. (WW) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 17 public stories across 9 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
WW International Reports Quarterly Results for Period Ended September 30
EQUITY | Nov 05, 2026, 03:57 PM UTC
M
WW International Q3 Revenue Slightly Beats Estimates on Subscription Growth
WW International’s third-quarter revenue slightly exceeded estimates, supported by clinical subscription growth.
EQUITY | Nov 05, 2026, 01:14 PM UTC
M
WW International Narrows 2026 Adjusted EBITDA View to $110M-$115M
EARNINGS | Nov 05, 2026, 12:22 PM UTC
L
WW International Reports Third-Quarter EPS of $1.51
EARNINGS | Nov 05, 2026, 12:22 PM UTC
M
WW International Narrows 2026 Revenue View to $625M–$630M
EARNINGS | Nov 05, 2026, 12:22 PM UTC
M
US Consumer Sentiment Index Falls 5.3 Points to 45.2 in October
The LSEG/Ipsos Primary Consumer Sentiment Index fell 5.3 points from September to 45.2 in October, its lowest reading since October 2011. The survey was taken Sept. 25 through Oct. 1.
MACRO | Oct 16, 2026, 08:43 PM UTC
L
WeightWatchers (WW) Stock Trades Up, Here Is Why
What Happened? Shares of personal wellness company WeightWatchers NASDAQ:WW jumped 8.9% in the pre-market session after the company announced a collaboration with Google Health Enterprise to integrate wearable technology
EQUITY | Sep 29, 2026, 02:11 PM UTC
M
WeightWatchers shares drop 14.8% after CEO transition announced
WeightWatchers shares (WW) fell 14.8% in the afternoon session. The company said Stephen Bye will become President, Chief Executive Officer and a Board member effective this fall.
EQUITY | Sep 09, 2026, 04:27 PM UTC
L
WW International appoints Stephen Bye as president and CEO
WW International named Stephen Bye as president and chief executive, effective this fall. The appointment follows Tara Comonte’s resignation earlier this year, with no interim CEO named.
EQUITY | Sep 09, 2026, 12:41 PM UTC
L
WW appoints Stephen J. Bye as president, CEO and director
WW appointed Stephen J. Bye as president and chief executive officer and as a director, with a mutually agreed commencement date on or before Nov. 27, 2026.
REGULATION | Sep 09, 2026, 12:03 PM UTC
L
Weight Watchers appoints Stephen Bye as chief executive officer
Weight Watchers Appoints Stephen Bye as Chief Executive Officer.
EQUITY | Sep 09, 2026, 12:02 PM UTC
L
WW - Weight Watchers to Participate in Morgan Stanley Annual Global Healthcare Conference
WW - Weight Watchers to Participate in Morgan Stanley Annual Global Healthcare Conference
EQUITY | Sep 03, 2026, 12:00 PM UTC
L
WW International director reports 7,235-share transaction
WW International director Nikolaj H P Sjoqvist reports a Form 4P transaction involving 7,235 shares at $13.84, valued at $100,132.
REGULATION | Aug 20, 2026, 08:02 PM UTC
L
WW International Affirms FY2026 Sales Guidance of $620.000M-$635.000M vs $632.183M Est
WW International (NASDAQ: WW ) affirms FY2026 sales outlook from $620.000 million-$635.000 million to $620.000 million-$635.000 million vs $632.183 million estimate.
EARNINGS | Aug 05, 2026, 08:10 PM UTC
L
WW - Weight Watchers Announces Second Quarter 2026 Results
WW - Weight Watchers Announces Second Quarter 2026 Results
EARNINGS | Aug 05, 2026, 08:01 PM UTC
H
WW International Partners With Sam's Club To Combine Expert Guidance, Nutrition Counseling, Affordable Healthy Foods And Trusted Pharmacy Se
Sam's Club Plus members may receive a complimentary three-month Weight Watchers Core membership, while all Sam's Club members can save up to 50% on select Weight Watchers programs Collaboration connects medication suppor
EARNINGS | Jul 09, 2026, 12:06 PM UTC
H
WW International's Weight Watchers Med+ Will Support Medicare Members Seeking Access To GLP-1s Under The Medicare GLP-1 Bridge Program
Through the Medicare GLP-1 Bridge Program, eligible beneficiaries purchase GLP-1 medications for weight loss, including Zepbound®, KwikPen®, Foundayo®, and Wegovy® pen and pill, for $50 per month. The program will run fr
EARNINGS | Jun 30, 2026, 12:04 PM UTC